Do you want to read an article? Please log in or register.
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
COVID-19
Related content
COVID-19
Pandémie de COVID-19 : un défi et une chance pour la santé mentale de la population
healthbook TIMES
RECOMMENDED
COVID-19
The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Kyriakoulis KG, Kollias A, Poulakou G, Kyriakoulis IG, Trontzas IP, Charpidou A, Syrigos K
doi: 10.3390/jcm10194462
RECOMMENDED
COVID-19
Lung function and breathing patterns in hospitalised COVID-19 survivors: a review of post-COVID-19 Clinics
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Stockley JA, Alhuthail EA, Coney AM, Parekh D, Geberhiwot T, Gautum N, Madathil SC, Cooper BG
doi: 10.1186/s12931-021-01834-5
COMMENTED
COVID-19
Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care
Wander PL, Lowy E, Beste LA, Tulloch-Palomino L, Korpak A, Peterson AC, Kahn SE, Boyko EJ
doi: 10.2337/dc21-1351
COVID-19Cardiovascular
COVID-19 et maladies cardiovasculaires : une association à double sens
healthbook TIMES
RECOMMENDED
COVID-19
A case of acquired immunodeficiency syndrome-related Kaposi sarcoma in a patient with COVID-19 - A brief review of HIV-COVID Co-infection and its Therapeutic challenges!
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med Case Rep
Nasrullah A, Patel S, Ud Din MT, Javed A, Arshad H, Raja A, Dumont T
doi: 10.1016/j.rmcr.2021.101524
RECOMMENDED
COVID-19
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur J Cancer
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C
doi: 10.1016/j.ejca.2021.10.014
RECOMMENDED
COVID-19
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Agrawal U, Katikireddi SV, McCowan C, Mulholland RH, Azcoaga-Lorenzo A, Amele S, Fagbamigbe AF, Vasileiou E, Grange Z, Shi T, Kerr S, Moore E, Murray JLK, Shah SA, Ritchie L, O'Reilly D, Stock SJ, Beggs J, Chuter A, Torabi F, Akbari A, Bedston S, McMenamin J, Wood R, Tang RSM, de Lusignan S, Hobbs FDR, Woolhouse M, Simpson CR, Robertson C, Sheikh A
doi: 10.1016/S2213-2600(21)00380-5
COVID-19
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
JAMA Intern Med
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI, HEP-COVID Investigators.
doi: 10.1001/jamainternmed.2021.6203